European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders

被引:32
作者
van den Bersselaar, Luuk R. [1 ,2 ]
Heytens, Luc [3 ,4 ,5 ]
Silva, Helga C. A. [6 ]
Reimann, Jens [7 ]
Tasca, Giorgio [8 ]
Diaz-Cambronero, Oscar [9 ]
Lokken, Nicoline [10 ]
Hellblom, Anna [11 ]
Hopkins, Philip M. [12 ,13 ]
Rueffert, Henrik [14 ]
Bastian, Boerge [14 ]
Vilchez, Juan Jesus [15 ]
Gillies, Robyn [16 ]
Johannsen, Stephan [17 ]
Veyckemans, Francis [18 ]
Muenster, Tino [19 ]
Klein, Andrea [20 ,21 ]
Litman, Ron [22 ]
Jungbluth, Heinz [23 ,24 ]
Riazi, Sheila [25 ]
Voermans, Nicol C. [2 ]
Snoeck, Marc M. J. [1 ]
机构
[1] Canisius Wilhelmina Hosp Nijmegen, Dept Anaesthesiol, Malignant Hyperthermia Invest Unit, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands
[3] Univ Antwerp, Univ Hosp Antwerp, Dept Anaesthesiol, Malignant Hyperthermia Res Unit, Antwerp, Belgium
[4] Univ Antwerp, Univ Hosp Antwerp, Dept Neurol, Malignant Hyperthermia Res Unit, Antwerp, Belgium
[5] Born Bunge Inst, Antwerp, Belgium
[6] Sao Paulo Fed Univ, Dept Surg, Malignant Hyperthermia Unit, Discipline Anaesthesia Pain & Intens Care, Sao Paulo, Brazil
[7] Univ Bonn, Dept Neurol, Med Ctr, Bonn, Germany
[8] A Gemelli Univ Polyclin Fdn, Sci Inst Res & Hlth Care, UOC Neurol, Rome, Italy
[9] La Fe Univ & Polytech Hosp, Dept Anaesthesiol, Malignant Hyperthermia Unit, Perioperat Med Res Grp, Valencia, Spain
[10] Copenhagen Univ Hosp, Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark
[11] Skane Univ Hosp Lund, Dept Intens & Perioperat Care, Lund, Sweden
[12] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds, W Yorkshire, England
[13] St James Univ Hosp, Malignant Hyperthermia Invest Unit, Leeds, W Yorkshire, England
[14] Univ Hosp Leipzig, Dept Anaesthesiol Intens Care Pain Therapy, Malignant Hyperthermia Invest Unit, Schkeuditz Helios Clin, Leipzig, Germany
[15] La Fe Hosp, Neuromuscular Ctr, Neuromuscular Res Grp La Fe IIS & CIBERER, UIP & ERN EURO NMD, Valencia, Spain
[16] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Malignant Hyperthermia Diagnost Unit, Parkville, Vic, Australia
[17] Univ Hosp Wurzburg, Ctr Malignant Hyperthermia, Dept Anaesthesiol Intens Care Emergency & Pain Me, Wurzburg, Germany
[18] Lille Univ Hosp Ctr, Jeanne de Flandre Hosp, Paediat Anaesthesia Clin, Lille, France
[19] Hosp Order St John God, Dept Anaesthesia & Intens Care Med, Regensburg, Germany
[20] Univ Childrens Hosp UKBB, Dept Paediat Neurol, Basel, Switzerland
[21] Univ Bern, Bern Univ Hosp, Dept Paediat, Div Neuropaediat Dev & Rehabil,Inselspital, Bern, Switzerland
[22] Childrens Hosp Philadelphia, Dept Anaesthesiol & Crit Care, Philadelphia, PA USA
[23] Natl Hlth Serv Fdn Trust, Dept Paediat Neurol, Neuromuscular Serv,Guys & St Thomas Hosp, Evelinas Children Hosp, London, England
[24] Kings Coll London, Fac Life Sci & Med, Randall Ctr Cell & Mol Biophys, Muscle Signalling Sect, London, England
[25] Univ Toronto, Univ Hlth Network, Dept Anaesthesiol & Pain Med, Malignant Hyperthermia Invest Unit, Toronto, ON, Canada
关键词
anaesthesia; malignant hyperthermia; myopathy; neuromuscular disorders; perioperative care; DUCHENNE MUSCULAR-DYSTROPHY; MALIGNANT HYPERTHERMIA; MITOCHONDRIAL DISEASE; MYOTONIC-DYSTROPHY; PERIOPERATIVE MANAGEMENT; CONGENITAL MYOPATHIES; PERIODIC PARALYSIS; MUTATION ANALYSIS; MUSCLE-RELAXANTS; CARDIAC-ARREST;
D O I
10.1111/ene.15526
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Patients with neuromuscular conditions are at increased risk of suffering perioperative complications related to anaesthesia. There is currently little specific anaesthetic guidance concerning these patients. Here, we present the European Neuromuscular Centre (ENMC) consensus statement on anaesthesia in patients with neuromuscular disorders as formulated during the 259th ENMC Workshop on Anaesthesia in Neuromuscular Disorders. Methods International experts in the field of (paediatric) anaesthesia, neurology, and genetics were invited to participate in the ENMC workshop. A literature search was conducted in PubMed and Embase, the main findings of which were disseminated to the participants and presented during the workshop. Depending on specific expertise, participants presented the existing evidence and their expert opinion concerning anaesthetic management in six specific groups of myopathies and neuromuscular junction disorders. The consensus statement was prepared according to the AGREE II (Appraisal of Guidelines for Research & Evaluation) reporting checklist. The level of evidence has been adapted according to the SIGN (Scottish Intercollegiate Guidelines Network) grading system. The final consensus statement was subjected to a modified Delphi process. Results A set of general recommendations valid for the anaesthetic management of patients with neuromuscular disorders in general have been formulated. Specific recommendations were formulated for (i) neuromuscular junction disorders, (ii) muscle channelopathies (nondystrophic myotonia and periodic paralysis), (iii) myotonic dystrophy (types 1 and 2), (iv) muscular dystrophies, (v) congenital myopathies and congenital dystrophies, and (vi) mitochondrial and metabolic myopathies. Conclusions This ENMC consensus statement summarizes the most important considerations for planning and performing anaesthesia in patients with neuromuscular disorders.
引用
收藏
页码:3486 / 3507
页数:22
相关论文
共 105 条
[1]   Diagnosis and Treatment of Mitochondrial Myopathies [J].
Ahmed, Syeda T. ;
Craven, Lyndsey ;
Russell, Oliver M. ;
Turnbull, Doug M. ;
Vincent, Amy E. .
NEUROTHERAPEUTICS, 2018, 15 (04) :943-953
[2]   Prevalence of Congenital Myopathies in a Representative Pediatric United States Population [J].
Amburgey, Kimberly ;
McNamara, Nancy ;
Bennett, Lindsey R. ;
McCormick, M. Eileen ;
Acsadi, Gyula ;
Dowling, James J. .
ANNALS OF NEUROLOGY, 2011, 70 (04) :662-665
[3]   Diagnostic challenges in metabolic myopathies [J].
Angelini, Corrado ;
Marozzo, Roberta ;
Pegoraro, Valentina ;
Sacconi, Sabrina .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (12) :1287-1298
[4]  
[Anonymous], 2014, ASA Physical Status Classification System
[5]  
[Anonymous], MYASTH GRAV FDN AM M
[6]  
[Anonymous], 2008, SIGN 50. A guideline developers handbook
[7]   Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses [J].
Bandschapp, Oliver ;
Iaizzo, Paul A. .
PEDIATRIC ANESTHESIA, 2013, 23 (09) :824-833
[8]   McArdle's disease and anaesthesia:: Case reports.: Review of potential problems and association with malignant hyperthermia [J].
Bollig, G ;
Mohr, S ;
Ræder, J .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2005, 49 (08) :1077-1083
[9]   AGREE II: advancing guideline development, reporting and evaluation in health care [J].
Brouwers, Melissa C. ;
Kho, Michelle E. ;
Browman, George P. ;
Burgers, Jako S. ;
Cluzeau, Francoise ;
Feder, Gene ;
Fervers, Beatrice ;
Graham, Ian D. ;
Grimshaw, Jeremy ;
Hanna, Steven E. ;
Littlejohns, Peter ;
Makarski, Julie ;
Zitzelsberger, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) :E839-E842
[10]   Cisatracurium pharmacodynamics in patients with oculopharyngeal muscular dystrophy [J].
Caron, MJ ;
Girard, F ;
Girard, DC ;
Boudreault, D ;
Brais, B ;
Nassif, E ;
Chouinard, P ;
Ruel, M ;
Duranceau, A .
ANESTHESIA AND ANALGESIA, 2005, 100 (02) :393-397